Document is current
Any future updates will be listed below
-
Authors
Devasia, Anup Joseph http://orcid.org/0000-0002-3587-8601
Chari, Ajai http://orcid.org/0000-0002-0405-7480
Lancman, Guido
- License Information
-
More Information
Article History
Received: 24 July 2024
Revised: 29 August 2024
Accepted: 2 September 2024
First Online: 12 September 2024
Competing interests
: AJD has no conflicts to declare. AC receives consultancy from Abbvie, Adaptive, Amgen, Antengene, Bristol Myers Squibb, Forus, Genetech/Roche, Glaxo Smith Klein, Janssen, Karyopharm, Millenium/Takeda, Sanofi/Genzyme; and research funding from Janssen. GL receives consultancy from Janssen and Takeda, honoraria from Janssen, Takeda, Forus, Sanofi & Pfizer.
